Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.5373
-0.0538-9.10%
Post-market: 0.54680.0095+1.77%18:33 EDT
Volume:391.17K
Turnover:219.20K
Market Cap:49.31M
PE:-0.36
High:0.5900
Open:0.5804
Low:0.5370
Close:0.5911
Loading ...

Verrica Pharmaceuticals Inc - Offering Includes Series a and B Warrants for 23.6 Mln Shares Each

THOMSON REUTERS
·
21 Nov 2024

BRIEF-Verrica Announces Proposed Public Offering

Reuters
·
21 Nov 2024

Verrica Announces Proposed Public Offering

THOMSON REUTERS
·
21 Nov 2024

Press Release: Verrica Announces Proposed Public Offering

Dow Jones
·
21 Nov 2024

Verrica Pharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

HC Wainwright Downgrades Verrica Pharmaceuticals to Neutral

MT Newswires Live
·
06 Nov 2024

Verrica Pharmaceuticals Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
06 Nov 2024

S&P 500 Gains 1%; Vimeo Shares Spike Higher

Benzinga
·
06 Nov 2024

Verrica Pharmaceuticals Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $2 From $10

THOMSON REUTERS
·
05 Nov 2024

RBC downgrades Verrica Pharmaceuticals on ‘uncertain path’ forward

TIPRANKS
·
05 Nov 2024

Shares of Verrica Pharmaceuticals Tumble Following 3Q Results, Operational Changes

Dow Jones
·
05 Nov 2024

Verrica Pharmaceuticals Q3 Adj $(0.43) Misses $(0.37) Estimate, Sales $(1.78M) Miss $4.63M Estimate

Benzinga
·
05 Nov 2024

Verrica Pharmaceuticals Inc - Appoints DR. Jayson Rieger as CEO and John Kirby as Interim CFO

THOMSON REUTERS
·
05 Nov 2024

Verrica Pharmaceuticals Q3 Collaboration Revenue USD 100 Thousand

THOMSON REUTERS
·
05 Nov 2024

Verrica Pharmaceuticals Q3 Basic EPS USD -0.49

THOMSON REUTERS
·
05 Nov 2024

Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

GlobeNewswire
·
05 Nov 2024